Gene · 341
Papers2,927
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 2,927
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma. | Cancer Cell | 2022 | 36379208 | PubTator, text mining | PubMed |
| Niclosamide targets the dynamic progression of macrophages for the resolution of endometriosis in a mouse model. | Commun Biol | 2022 | 36369244 | PubTator, text mining | PubMed |
| ANGPTL3 as a Drug Target in Hyperlipidemia and Atherosclerosis. | Curr Atheroscler Rep | 2022 | 36367663 | PubTator, text mining | PubMed |
| Obstructive Sleep Apnoea and Lipid Metabolism: The Summary of Evidence and Future Perspectives in the Pathophysiology of OSA-Associated Dyslipidaemia. | Biomedicines | 2022 | 36359273 | PubTator, text mining | PubMed |
| Classic and New Markers in Diagnostics and Classification of Breast Cancer. | Cancers (Basel) | 2022 | 36358862 | PubTator, text mining | PubMed |
| Exploring the Role of Lipid-Binding Proteins and Oxidative Stress in Neurodegenerative Disorders: A Focus on the Neuroprotective Effects of Nutraceutical Supplementation and Physical Exercise. | Antioxidants (Basel) | 2022 | 36358488 | PubTator, text mining | PubMed |
| Single cell profiling of primary and paired metastatic lymph node tumors in breast cancer patients. | Nat Commun | 2022 | 36357424 | PubTator, text mining | PubMed |
| Proteomic analysis identifies a signature of disease severity in the plasma of COVID-19 pneumonia patients associated to neutrophil, platelet and complement activation. | Clin Proteomics | 2022 | 36348270 | PubTator, text mining | PubMed |
| Human endometrial cell-type-specific RNA sequencing provides new insights into the embryo-endometrium interplay. | Hum Reprod Open | 2022 | 36339249 | PubTator, text mining | PubMed |
| Establishment and validation of a polygene prognostic model for clear cell renal cell carcinoma. | Front Genet | 2022 | 36338999 | PubTator, text mining | PubMed |
| Heterogeneity of glioblastoma stem cells in the context of the immune microenvironment and geospatial organization. | Front Oncol | 2022 | 36338705 | PubTator, text mining | PubMed |
| APOE ɛ4 allele and TOMM40-APOC1 variants jointly contribute to survival to older ages. | Aging Cell | 2022 | 36330582 | PubTator, text mining | PubMed |
| Remnant cholesterol and atherosclerotic cardiovascular disease: Metabolism, mechanism, evidence, and treatment. | Front Cardiovasc Med | 2022 | 36324753 | PubTator, text mining | PubMed |
| GPX2 predicts recurrence-free survival and triggers the Wnt/β-catenin/EMT pathway in prostate cancer. | PeerJ | 2022 | 36312753 | PubTator, text mining | PubMed |
| Alterations of HDL's to piHDL's Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies. | Pharmaceuticals (Basel) | 2022 | 36297390 | PubTator, text mining | PubMed |
| Genetic Determinants of 25-Hydroxyvitamin D Concentrations and Their Relevance to Public Health. | Nutrients | 2022 | 36297091 | PubTator, text mining | PubMed |
| The Citrus Flavonoid Nobiletin Downregulates Angiopoietin-like Protein 3 (ANGPTL3) Expression and Exhibits Lipid-Modulating Effects in Hepatic Cells and Adult Zebrafish Models. | Int J Mol Sci | 2022 | 36293338 | PubTator, text mining | PubMed |
| Longitudinal Serum Protein Analysis of Women with a High Risk of Developing Breast Cancer Reveals Large Interpatient Versus Small Intrapatient Variations: First Results from the TESTBREAST Study. | Int J Mol Sci | 2022 | 36293255 | PubTator, text mining | PubMed |
| Integrated Quantitative Targeted Lipidomics and Proteomics Reveal Unique Fingerprints of Multiple Metabolic Conditions. | Biomolecules | 2022 | 36291648 | PubTator, text mining | PubMed |
| Proteomics-Based Identification of Dysregulated Proteins in Breast Cancer. | Proteomes | 2022 | 36278695 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/341/papers?page=32